Month: May 2013

Seagate Technology plc ( STX ) reported third-quarter 2013 earnings per share of $1.26, which exceeded the Zacks Consensus Estimate of $1.19. Revenue Seagate reported revenues of $3.53 billion in the third quarter of 2013, down 20.8% from $4.45 billion in the year-ago period. The Hard Disk Drive (HDD) industry continues to witness a lack of consistent visibility due to weak customer response globally […]

General Motors Co. ( GM ) reported a 28.0% fall in earnings to 67 cents per share in the first quarter of the year from 93 cents in the same quarter of 2012 (all excluding special items) due to lower earnings generated from the company’s all geographic operations except Europe. Despite this, the automaker’s earnings exceeded the Zacks Consensus Estimate by 11 cents per share. […]

Natural gas-focused energy company Questar Corporation ( STR ) reported weak first-quarter 2013 earnings. Earnings per share came in at 41 cents, down 2.4% from the profit of 42 cents earned in the prior-year quarter, mainly due to higher depreciation and administrative expenses. […]

Healthcare Realty Trust Inc. ( HR ), a real estate investment trust (REIT), reported first quarter 2013 normalized funds from operations (FFO) per share of 32 cents, in line with the Zacks Consensus Estimate, but a cent lower year over year. The company experienced a rise in revenues in the quarter, which also exceeded the Zacks Consensus Estimate […]

Medical technology major , Becton, Dickinson and Company ( BDX ) reported second-quarter fiscal 2013 adjusted earnings per share from continuing operations of $1.44, beating the Zacks Consensus Estimate of $1.35 per share. The company reported net income from continuing operations of $276.1 million (or $1.39 per share). Total net income was $275.6 million (or $1.39 per share) […]

We currently maintained a Neutral recommendation on Praxair Inc. ( PX ), being optimistic about the company’s long-term growth opportunities and cautious of near-term concerns surrounding it. […]

Sempra Energy ’s ( SRE ) first quarter 2013 earnings per share of 97 cents per share missed the Zacks Consensus Estimate of $1.02 per share. Earnings were flat year over year. Including a one-time charge of 26 cents per share for income tax expense related to reorganization in connection with the initial public offering of Sempra Energy's Mexican subsidiary, the company reported earnings of 72 cents versus 97 cents per share in the first quarter of 2012. […]

Kimco Realty Corporation ( KIM ), a real estate investment trust (REIT), reported adjusted FFO (funds from operations) per share of 32 cents, in line with the Zacks Consensus Estimate and rising by a cent from the prior-year quarter. The results were aided by better-than expected growth in revenues and net operating income, which represented the highest quarterly increase since 2007. The company has also raised the lower end of its previously issued guidance […]

Ohio-based independent oil refiner and marketer Marathon Petroleum Corporation ( MPC ) reported an impressive first quarter of 2013 backed by favorable market conditions and increased earnings in all its segments. These were partially offset by lower refining margins. Marathon reported earnings per share of $2.17, in line with the Zacks Consensus Estimate […]

BRE Properties Inc. ’s ( BRE ) first quarter 2013 core fund from operations (FFO) of 58 cents per share fell a penny short of the Zacks Consensus Estimate of 59 cents. […]

Harman International Industries Inc. ( HAR ) reported earnings of 79 cents per share in the third quarter of 2013, which comfortably surpassed the Zacks Consensus Estimate by 16 cents. […]

Recently, Haemonetics ( HAE ) completed the acquisition of Hemerus Medical, a Minn.-based company that develops technologies for the collection of whole blood, and processing and storage of blood components. Notably, Haemonetics earlier paid $1 million in this regard and waited for Hemerus to receive approval from the US Food and Drug Administration (FDA) for SOLX red cell storage solution. According to its plan, following the recent FDA approval for Hemerus' New Drug Application for the SOLX’ whole blood collection system for 8-hour storage, the company closed the deal paying another $23 million. […]

Pharmacyclics Inc. ’s ( PCYC ) first quarter 2013 loss of 73 cents per share was wider than the year-ago loss of 19 cents and the loss of 8 cents hinted at by the Zacks Consensus Estimate. […]

DexCom, Inc. ( DXCM ), a player in the glucose monitoring market, reported first quarter 2013 adjusted loss per share of 16 cents, narrower than the Zacks Consensus Estimate of a loss of 17 cents per share. Revenues Revenues surged 47% year over year to $29.6 million in the first quarter, beating the Zacks Consensus Estimate of $28 million […]

Leading distributor of pharmaceuticals and medical supplies Cardinal Health, Inc. ( CAH ) posted third-quarter fiscal 2013 adjusted (excluding one-time charges and gains) earnings per share from continuing operations of $1.20, thereby beating the Zacks Consensus Estimate of 95 cents as well as the year-ago earnings of 94 cents per share. Net earnings from continuing operations were $346 million ($1.00 per share), up 4% year over year […]